The Pharma Report: Get Back in Shape

Once bloated and winded, the drug industry has made strides at shaping up its US operations, shedding excess pounds and taking steps to shore up long-term health. That's a start. Getting back into real shape will take a package of exercises that build muscle in more ways than one.

"It is almost like the industry is pulling out the couch cushions to look for spare change"
Tim Anderson, Analyst, Sanford Bernstein

CLICK HERE for key data, trends and insights on the state of the pharma industry, including...

• Exclusive interviews with leading industry watchers, including Tim Anderson, analyst, Sanford Bernstein; Harris Kaplan, CEO, Healogix; and Wayne Pines, president, regulatory services and healthcare, APCO Worldwide.
• Individual reports on the Top 20 pharma companies, including US and global revenue, top brands, promotional spend, R&D spend, planned launches and patent expirations.
• The latest industry data from IMS Health and Cegedim Strategic Data, including:

—Top 20 brands by sales
—Top 20 classes by sales
—Promotional spend breakouts for DTC, Detailing, eDetailing, Meeting and Journals
—Patent expirations through 2016

Read the story; share it instantly on Facebook, Twitter, GooglePlus and Linkedin; post your own comments; and view or download a PDF of the beautifully designed original layout from the print edition of MM&M. It's all FREE and just one click away.